176 related articles for article (PubMed ID: 3022915)
1. Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3.
Hersey P; Schibeci SD; Townsend P; Burns C; Cheresh DA
Cancer Res; 1986 Dec; 46(12 Pt 1):6083-90. PubMed ID: 3022915
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside.
Welte K; Miller G; Chapman PB; Yuasa H; Natoli E; Kunicka JE; Cordon-Cardo C; Buhrer C; Old LJ; Houghton AN
J Immunol; 1987 Sep; 139(6):1763-71. PubMed ID: 2887619
[TBL] [Abstract][Full Text] [Related]
3. Recognition of cell surface GD3 by monoclonal antibody anti-6C2 in rheumatoid arthritis synovial fluid: expression on human T cells with transendothelial migratory activity.
Homma T; Hosono O; Iwata S; Ando S; Sasaki K; Nishi T; Kawasaki H; Tanaka H; Morimoto C
Arthritis Rheum; 2001 Feb; 44(2):296-306. PubMed ID: 11229459
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cytotoxic and proliferative responses of lymphocytes from melanoma patients by incubation with monoclonal antibodies against ganglioside GD3.
Hersey P; MacDonald M; Burns C; Cheresh DA
Cancer Immunol Immunother; 1987; 24(2):144-50. PubMed ID: 3493846
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of interleukin-2 production and its binding by monoclonal antibodies to the gangliosides GD3 and GD2.
Schibeci S; Hersey P; Cheresh D
Cancer Immunol Immunother; 1989; 29(2):109-17. PubMed ID: 2524255
[TBL] [Abstract][Full Text] [Related]
7. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
Geppert TD; Lipsky PE
J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of GD3 ganglioside with CD45RO in resting and activated human T lymphocytes.
Merritt WD; Taylor BJ; Der-Minassian V; Reaman GH
Cell Immunol; 1996 Oct; 173(1):131-48. PubMed ID: 8871609
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
[TBL] [Abstract][Full Text] [Related]
10. Cell matrix adhesion-related proteins VLA-1 and VLA-2: regulation of expression on T cells.
Hemler ME; Jacobson JG
J Immunol; 1987 May; 138(9):2941-8. PubMed ID: 3106495
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human T lymphocyte mitogenesis by antibodies to CD3.
Davis L; Vida R; Lipsky PE
J Immunol; 1986 Dec; 137(12):3758-67. PubMed ID: 3097131
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin.
Mills GB; Lee JW; Cheung RK; Gelfand EW
J Immunol; 1985 Nov; 135(5):3087-93. PubMed ID: 2995486
[TBL] [Abstract][Full Text] [Related]
13. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of anti-GD3-ganglioside antibody-induced proliferation of human CD8+ T cells by CD16+ natural killer cells.
Claus C; Schlaak J; Dittmayer M; Meyer zum Büschenfelde K; Dippold W
Eur J Immunol; 1994 May; 24(5):1208-12. PubMed ID: 8181530
[TBL] [Abstract][Full Text] [Related]
15. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
16. Anti-GD3 chimeric sFv-CD28/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors.
Lo AS; Ma Q; Liu DL; Junghans RP
Clin Cancer Res; 2010 May; 16(10):2769-80. PubMed ID: 20460472
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
Redelman D
Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
[TBL] [Abstract][Full Text] [Related]
18. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
19. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.
Helfand SC; Dickerson EB; Munson KL; Padilla ML
Cancer Res; 1999 Jul; 59(13):3119-27. PubMed ID: 10397254
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the responsiveness of alveolar T cells to proliferative stimuli and on surface antigens].
Yamaguchi E
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):224-36. PubMed ID: 8509065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
